I would think an update on the below would be coming this week (Monday) on the below, hopefully announcing the exercising of the option and completion of full licensing (First announced Dec 1st). There could also be a 3rd dose cohort update as early as later this month seeing the first patient was dosed back on the 25th of February. This would allow for three patients to be dosed consecutively and pass the 28-day follow up. Let's see what unfolds.
Ann: Virtual investor conference presentation 2 May 2022, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $23.10K | 1.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1693528 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 192703 | 1 |
View Market Depth
| Last trade - 11.50am 24/06/2024 (20 minute delay) ? |
| CHM (ASX) Chart |